The 35th annual Lorne Cancer conference was hosted last week, delivering a quality lineup of presenters and networking opportunities. Oncology One was proud to be the Presentation Award Sponsor. Our new Director, Dr Ton Bunt, was visiting from the US […]
Oncology One has today announced it has appointed Dr Ton Bunt as a Non-Executive Director, who brings vital expertise to the Board in the areas of product development and commercialisation. Oncology One Chair, Mary Harney, said: “The Oncology One Board […]
Oncology One’s Head of Drug Discovery, Dr Richard Foitzik, is heading to Perth to participate in AusBiotech’s upcoming events, the annual AusBiotech Conference (26-28 Oct 2022) and AusBioinvest22 (27 Oct 2022). AusBiotech 2022 will address issues essential to growing commercial […]
Oncology One is proud to announce it will provide funding for an award at the Zero Childhood Cancer National Symposium to be hosted in Sydney from 26-27 October this week. Oncology One Chair, Mary Harney, said: “The Zero Childhood Cancer […]
Oncology One CEO, Dr Joanne Boag, is this week attending BIO-Europe – a meeting of more than 4650 delegates from around the world in Leipzig, Germany, from 24-26 October. Dr Boag said: “This is a premier networking event for life […]
Oncology One CEO, Dr Joanne Boag, was invited to participate in the BioMelbourne Network’s BioForum event this week, responding to the theme “Translating Innovation: From Lab Bench to Marketplace”. She discussed key challenges and opportunities that exist in the translation […]
It was a delight to be part of the 34th Lorne Cancer Conference late last week, and to participate in the face-to-face exchange of ideas with some of Australia’s leading cancer researchers. As sponsors of the conference’s first Oral Presentation Awards, […]
Oncology One is committed to being at the forefront of industry conversations and scientific progress in the cancer space. That’s why our team is attending the 34th Lorne Cancer Conference this week. This is Australia’s preeminent multidisciplinary cancer research event, […]
Oncology One has today announced a new partnership with WEHI (Walter and Eliza Hall Institute of Medical Research) to develop new drugs for the treatment of cancer, in collaboration with Curtin University. The collaboration centres on the development of novel […]
Australian biotechnology company, Oncology One, has today announced the appointment of a new Non-Executive Director, Professor Shelley Dolan, a highly regarded leader in oncology and CEO of Peter MacCallum Cancer Centre. 27 October 2021, Melbourne, Australia: Australian biotech company, Oncology […]
